{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:47:35Z","timestamp":1789778855108,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajpc.2026.101425","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:53:28Z","timestamp":1770411208000},"page":"101425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A real-world evaluation of longitudinal healthcare expenses in a health system registry of type-2 diabetes mellitus and cardiovascular disease enabled by the 21st century cures act"],"prefix":"10.1016","volume":"25","author":[{"given":"Lovedeep S.","family":"Dhingra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline F.","family":"Pedroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Aminorroaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigar","family":"Rajpura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Tonnu-Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9467-6199","authenticated-orcid":false,"given":"Rohan","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101425_bib0001","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","article-title":"Economic burden of cardiovascular disease in type 2 diabetes: a systematic review","volume":"21","author":"Einarson","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.ajpc.2026.101425_bib0002","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S2213-8587(17)30097-9","article-title":"The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study","volume":"5","author":"Bommer","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101425_bib0003","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.37765\/ajmc.2020.43491","article-title":"Health care resource utilization among patients with T2D and cardiovascular-, heart failure-, or renal-related hospitalizations","volume":"26","author":"Annavarapu","year":"2020","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ajpc.2026.101425_bib0004","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s13300-023-01430-4","article-title":"Atherosclerotic cardiovascular disease in type 2 diabetes: a retrospective, observational study of economic and clinical burden in Sweden","volume":"14","author":"Steen Carlsson","year":"2023","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ajpc.2026.101425_bib0005","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American diabetes association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101425_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006139","article-title":"Burden and consequences of financial hardship from medical bills among nonelderly adults with diabetes mellitus in the United States","volume":"13","author":"Caraballo","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajpc.2026.101425_bib0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11892-019-1265-8","article-title":"Patient-reported outcome measures in registry-based studies of type 2 diabetes mellitus: a systematic review","volume":"19","author":"Chen","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ajpc.2026.101425_bib0008","first-page":"S5","article-title":"Burden of illness in type 2 diabetes mellitus","volume":"24","author":"Cannon","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.ajpc.2026.101425_bib0009","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the U.S. in 2022","volume":"47","author":"Parker","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101425_bib0010","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMp2200089","article-title":"Real-world evidence - where are we now?","volume":"386","author":"Concato","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101425_bib0011","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2020.7858","article-title":"Digital health equity as a necessity in the 21st century cures act era","volume":"323","author":"Rodriguez","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101425_bib0012","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1310\/hpx5204-264","article-title":"21st century cures act","volume":"52","author":"Gabay","year":"2017","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.ajpc.2026.101425_bib0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjcard.2023.06.104","article-title":"Cardiovascular care innovation through data-driven discoveries in the electronic health record","volume":"203","author":"Dhingra","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2026.101425_bib0014","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jacc.2024.05.069","article-title":"Comparative effectiveness of second-line antihyperglycemic agents for cardiovascular outcomes: a multinational, federated analysis of LEGEND-T2DM","volume":"84","author":"Khera","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101425_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000651","article-title":"Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM","volume":"2","author":"Khera","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.ajpc.2026.101425_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/circ.150.suppl_1.4142708","article-title":"Abstract 4142708: digital registry for cardiometabolic conditions \u2013 diabetes mellitus (DIRECT-DM): a large, pragmatic, multisite, diverse longitudinal registry of type 2 diabetes","volume":"150","author":"Pedroso Camargos","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101425_bib0017","unstructured":"Clinical classifications software refined (CCSR). 2025 [cited 12 Feb 2025]. Available: https:\/\/hcup-us.ahrq.gov\/toolssoftware\/ccsr\/ccs_refined.jsp."},{"key":"10.1016\/j.ajpc.2026.101425_bib0018","unstructured":"MS-DRG Classifications and Software. 2025 [cited 18 Oct 2024]. Available: https:\/\/www.cms.gov\/medicare\/payment\/prospective-payment-systems\/acute-inpatient-pps\/ms-drg-classifications-and-software."},{"key":"10.1016\/j.ajpc.2026.101425_bib0019","unstructured":"Hospital charging information. 2025 [cited 12 Feb 2025]. Available: https:\/\/www.ynhh.org\/patients-visitors\/billing-insurance\/Pricing."},{"key":"10.1016\/j.ajpc.2026.101425_bib0020","unstructured":"21st Century Cures Act. In: U.S. Food and Drug Administration [Internet]. FDA; 31 Jan 2020 [cited 12 Feb 2025]. Available: https:\/\/www.fda.gov\/regulatory-information\/selected-amendments-fdc-act\/21st-century-cures-act."},{"key":"10.1016\/j.ajpc.2026.101425_bib0021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amepre.2020.02.016","article-title":"Financial hardship, healthcare utilization, and health among U.S. cancer survivors","volume":"59","author":"Zheng","year":"2020","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajpc.2026.101425_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jss.2020.05.095","article-title":"Financial hardship after traumatic injury: risk factors and drivers of out-of-pocket health expenses","volume":"256","author":"O\u2019Neill","year":"2020","journal-title":"J Surg Res"},{"key":"10.1016\/j.ajpc.2026.101425_bib0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21315\/mjms2019.26.1.3","article-title":"Determinants of household catastrophic health expenditure: a systematic review","volume":"26","author":"Azzani","year":"2019","journal-title":"Malays J Med Sci"},{"key":"10.1016\/j.ajpc.2026.101425_bib0024","unstructured":"Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO\/Europe). 2025 [cited 18 Feb 2025]. Available: https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/4989."},{"key":"10.1016\/j.ajpc.2026.101425_bib0025","unstructured":"NCI comorbidity index overview. 2025 [cited 18 Feb 2025]. Available: https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/considerations\/comorbidity.html."},{"key":"10.1016\/j.ajpc.2026.101425_bib0026","first-page":"188","article-title":"Charlson comorbidity index: ICD-9 update and ICD-10 translation","volume":"12","author":"Glasheen","year":"2019","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.ajpc.2026.101425_bib0027","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101425_bib0028","first-page":"421","article-title":"Medical costs associated with type 2 diabetes complications and comorbidities","volume":"19","author":"Li","year":"2013","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ajpc.2026.101425_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17696","article-title":"Catastrophic health expenditures across insurance types and incomes before and after the patient protection and affordable care act","volume":"3","author":"Liu","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpc.2026.101425_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015523","article-title":"Cumulative burden of financial hardship from medical bills across the spectrum of diabetes mellitus and Atherosclerotic cardiovascular disease among non-elderly adults in the United States","volume":"9","author":"Mszar","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2026.101425_bib0031","first-page":"280","article-title":"Differences in all-cause health care utilization and costs in a type 2 diabetes mellitus population with and without a history of cardiovascular disease","volume":"24","author":"Mehta","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.ajpc.2026.101425_bib0032","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/jama.2017.2481","article-title":"Enhancing transparency at the US food and drug administration","volume":"317","author":"Sharfstein","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101425_bib0033","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/09720634231154367","article-title":"Issues and challenges pertaining to financing in providing pricing transparency in the American health care industry","volume":"25","author":"Willis","year":"2023","journal-title":"J Health Manag"},{"key":"10.1016\/j.ajpc.2026.101425_bib0034","article-title":"Automated identification of heart failure with reduced ejection fraction using deep learning-based natural language processing","author":"Nargesi","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ajpc.2026.101425_bib0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.43925","article-title":"Natural language processing of clinical documentation to assess functional status in patients with heart failure","volume":"7","author":"Adejumo","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpc.2026.101425_bib0036","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.0276","article-title":"Development and assessment of a new framework for disease surveillance, prediction, and risk adjustment: the diagnostic items classification system","volume":"3","author":"Ellis","year":"2022","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.ajpc.2026.101425_bib0037","unstructured":"Middle America project. In: Echelon Insights [Internet]. 15 July 2022 [cited 16 Aug 2023]. Available: https:\/\/echeloninsights.com\/map\/."},{"key":"10.1016\/j.ajpc.2026.101425_bib0038","unstructured":"Fitch M.E. New haven county is now middle America, according to study. In: Connecticut Inside Investigator [Internet]. 20 Sept 2022 [cited 29 Aug 2023]. Available: https:\/\/insideinvestigator.org\/new-haven-county-is-now-middle-america-according-to-study\/."}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266666772600019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266666772600019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:41:46Z","timestamp":1775104906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266666772600019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"alternative-id":["S266666772600019X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101425","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A real-world evaluation of longitudinal healthcare expenses in a health system registry of type-2 diabetes mellitus and cardiovascular disease enabled by the 21st century cures act","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101425"}}